(Press-News.org) Researchers from Guillermo Montoya's team at the Spanish National Cancer Research Centre (CNIO), in collaboration with Isabelle Vernos' Group from the Centre for Genomic Regulation (CRG), have uncovered the molecular interaction between TACC3 and chTOG, key proteins in forming the internal cellular framework that enables and sustains cell division. Published today in Nature Communications, the observations may help to optimise current oncological therapies specifically designed to fight against this framework, named by the scientific community as microtubules.
KEY MOLECULES FOR CELLULAR PROLIFERATION
"During cell division, alterations in microtubule formation may bring about chromosome instability and aneuploidy. In other words, alterations in the number of chromosomes, which can lead to a tumour process," explains Montoya. "This is an underlying cause of tumours."
While the role of chTOG in microtubule assembly during cell division has been widely studied, not much is known regarding TACC3 and its contribution to the process.
The team of researchers uncovered the molecular basis of the interaction between these proteins, and how TACC3 recruits chTOG to the microtubules during cellular division. "Our results indicate that TACC3's function completely depends on this interaction, so that mutations in the latter prevent chTOG from correctly incorporating into the microtubules," states Montoya. Analyses were performed on the frog Xenopus laevis, an animal model widely used by researchers from around the world to study laws governing cellular division in depth.
RELEVANCE IN CANCER RESEARCH
One of the most used and most effective strategies in cancer treatment are drugs targeting microtubules, which halt the growth of tumour cells and induce apoptosis or programmed cellular death.
"Our study on the TACC3-chTOG interaction will allow cellular biologists and researchers on microtubule dynamics to better understand how microtubule assembly is regulated during cellular division," says Montoya, and he anticipates that "it could also help in developing new anti-microtubule drugs, providing more effective therapeutic options in cancer treatment."
INFORMATION:
This study was funded by the CONSOLIDER programme of the Ministry of Economy and Competitiveness, the Ramón Areces Foundation, and the Community of Madrid.
Reference article:
The XTACC3-XMAP215 association reveals an asymmetric interaction promoting microtubule elongation. Gulnahar B. Mortuza, et al. Nature Communications (2014)
A molecular mechanism involved in cellular proliferation characterized
The study defines an interaction between key proteins in cell division; The results may aid in improving oncological therapies designed to block these division processes, and therefore limit the proliferation and expansion of tumor cells
2014-09-29
ELSE PRESS RELEASES FROM THIS DATE:
New method to motivate students to reduce energy consumption
2014-09-29
The research found that a combination of a real-time feedback system together with a human energy delegate in eight halls of residence resulted in a reduction of 37% in energy consumption when compared to normal consumption. The savings were 1360.49 kWh, which is equivalent to a reduction of 713.71 kg of CO2 over four weeks.
In contrast, another eight halls, exposed only to the real-time feedback and a weekly email alert, resulted in saw a 3.5% reduction in energy consumption.
Student's energy-use behaviour is complex as they cannot easily identify how much electricity ...
Dolphins are attracted to magnets
2014-09-29
Dolphins are indeed sensitive to magnetic stimuli, as they behave differently when swimming near magnetized objects. So says Dorothee Kremers and her colleagues at Ethos unit of the Université de Rennes in France, in a study in Springer's journal Naturwissenschaften – The Science of Nature. Their research, conducted in the delphinarium of Planète Sauvage in France, provides experimental behavioral proof that these marine animals are magnetoreceptive.
Magnetoreception implies the ability to perceive a magnetic field. It is supposed to play an important role in how some ...
Human trafficking, an invisible problem
2014-09-29
This news release is available in Spanish. This study compares the existing legislation on this subject in European countries and analyzes both the level of protection afforded to the victims and the measures taken to avoid this crime; in addition, it proposes of code of best practices that favors the enactment of new European guidelines aimed at ending this activity. Specifically, it shows that one of the first obstacles to change is that the magnitude of the problem is not known, points out one of the authors of the report, Begoña Marugán Pintos, of the department ...
Evolutionary biology: It's not just for textbooks anymore
2014-09-29
Solving global challenges in food security, emerging diseases and biodiversity loss requires evolutionary thinking, argues a new study published online in Science Express that was co-authored by Bruce Tabashnik of the University of Arizona College of Agriculture and Life Sciences.
For the first time, an international team of nine scientists has reviewed progress in addressing a broad set of challenges in agriculture, medicine and environmental management using approaches that consider evolutionary histories and the likelihood of rapid adaptation to human activities.
The ...
IMPRESS trial data on continuing tyrosine kinase inhibitor therapy after resistance development in lung cancer reported
2014-09-29
Patients whose lung cancer has developed resistance to the drug gefitinib experience no statistically significant improvement in progression-free survival from continued treatment with the drug in addition to chemotherapy, a phase III trial presented at the ESMO 2014 Congress has shown.
The IMPRESS trial is a randomised phase III study that compared continuation of gefitinib in addition to chemotherapy against chemotherapy alone in patients with lung cancer that carried mutations in the EGFR cell surface receptor.
Gefitinib is a type of drug known as a tyrosine kinase ...
Pertuzumab adds 16 months survival benefit to trastuzumab and chemo treatment for HER2-positive breast cancer
2014-09-29
Patients with HER2-positive breast cancer that has spread to other parts of their body live around 16 months longer if treated with a combination of pertuzumab, trastuzumab and chemotherapy compared to those treated with trastuzumab and chemotherapy alone, updated results from the CLEOPATRA study reveal.
CLEOPATRA was a pivotal phase III study where researchers evaluated the safety and efficacy of pertuzumab, trastuzumb and chemotherapy in 808 patients with previously untreated HER2-positive metastatic breast cancer. HER2-positive metastatic breast cancer has historically ...
Adding cediranib to chemo improves progression-free survival for meta or recurrent cervical cancer
2014-09-29
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid.
In Europe, about 70% of patients with cervical cancer are cured by either surgery or chemo-radiotherapy. Those patients with recurrent or secondary cancer have a very poor outlook. Only about 20-30% have tumour shrinkage after conventional chemotherapy and survival ...
Many patients lack information about the use of targeted therapies, oncologists say
2014-09-29
More than three quarters of oncology specialists in Europe, South America and Asia believe their patients are not always well enough informed about the treatment options available to them, survey results have revealed at the ESMO 2014 Congress in Madrid, Spain.
The results come from an online survey of 895 doctors from 12 countries in Europe, South America and Asia. All were practicing oncology specialists, with more than three years' experience, treating more than fifteen patients a month.
While 82% of those surveyed believed that deciding on a course of treatment ...
Under-representation of women in oncology leadership positions
2014-09-29
A growing number of oncologists in Greece are female, but women continue to be under-represented in leadership positions, according to a survey reported at the ESMO 2014 Congress.
"In Greece, and across Europe, women oncologists still find it hard to access leadership or academic positions," said Dr Helena Linardou, Associate Director of the 1st Department of Oncology at the Metropolitan Hospital, Athens, Greece, who presented the survey results at the congress.
"Women are indeed increasingly choosing oncology specialties in Greece, however, most decision-making posts ...
Is expressive suppression effective in reducing negative emotion?
2014-09-29
A recent study based on a Chinese sample gives an answer to this question. The research shows that in Chinese culture, emotion- expressive suppression is not only able to dampen negative emotion effectively, but also dampen negative emotion faster than Cognitive reappraisal. This sheds much light on how to quickly regulate negative emotion in urgent situations, particularly when people from East-Asian cultures are concerned.
This study has been published in SCIENCE CHINA： Life Sciences (IN CHINESE) , which is titled "The efficiency of negative emotion regulation: ...
LAST 30 PRESS RELEASES:
Not all Hot Jupiters orbit solo
Study shows connection between childhood maltreatment and disease in later life
Discovery of two planets sheds new light on the formation of planetary systems
New West Health-Gallup survey finds incoming Trump administration faces high public skepticism over plans to lower healthcare costs
Reading signs: New method improves AI translation of sign language
Over 97 million US residents exposed to unregulated contaminants in their drinking water
New large-scale study suggests no link between common brain malignancy and hormone therapy
AI helps to identify subjective cognitive decline during the menopause transition
Machine learning assisted plasmonic absorbers
Healthy lifestyle changes shown to help low back pain
Waking up is not stressful, study finds
Texas A&M AgriLife Research aims for better control of widespread tomato spotted wilt virus
THE LANCET DIABETES & ENDOCRINOLOGY: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.
Floating solar panels could support US energy goals
Long before the L.A. fires, America’s housing crisis displaced millions
Breaking barriers: Collaborative research studies binge eating disorders in older Hispanic women
UVA receives DURIP grant for cutting-edge ceramic research system
Gene editing extends lifespan in mouse model of prion disease
Putting a lid on excess cholesterol to halt bladder cancer cell growth
Genetic mutation linked to higher SARS-CoV-2 risk
UC Irvine, Columbia University researchers invent soft, bioelectronic sensor implant
Harnessing nature to defend soybean roots
Yes, college students gain holiday weight too—but in the form of muscle not fat
Beach guardians: How hidden microbes protect coastal waters in a changing climate
Rice researchers unlock new insights into tellurene, paving the way for next-gen electronics
New potential treatment for inherited blinding disease retinitis pigmentosa
Following a 2005 policy, episiotomy rates have reduced in France without an overall increase in anal sphincter injuries during labor, with more research needed to confirm the safest rate of episiotomi
Rats anticipate location of food-guarding robots when foraging
The American Association for Anatomy announces their Highest Distinctions of 2025
Diving deep into dopamine
[Press-News.org] A molecular mechanism involved in cellular proliferation characterizedThe study defines an interaction between key proteins in cell division; The results may aid in improving oncological therapies designed to block these division processes, and therefore limit the proliferation and expansion of tumor cells